7/24/2020, 9:31 PM (Source: TeleTrader)
more TeleTrader news

CureVac files for IPO, plans to list on Nasdaq

Biopharmaceutical company CureVac B.V. filed for an initial public offering (IPO) on Friday, noting it plans to list on the Nasdaq exchange under the ticker CVAC.

CureVac listed the size of its offering as $100 million, which is expected to change, and noted it intends to use the funds raised in the offering to fund clinical research and expand manufacturing facilities.

Earlier this week, CureVac got a loan worth €75 million from the European Union for vaccine development, including one for the coronavirus. Furthermore, the firm announced it is partnering with GlaxoSmithKline plc (GSK) to work on the development of COVID-19 vaccines.

Baha Breaking News (BBN) / NP